Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (10342)	6/4/1999 8:37:00 AM
From: Catherine	Read Replies (1) \| Respond to of 17367

George, I, too, am an investor in Xoma. I've been following all the comments about the trial. I am confused about something, though, and I'm afraid if I went back and read all of the SI messages about the trial and the 62 who died I would be even more confused. Could you please explain something to me? If 62 patients out of 400-something died is that considered a low number and is it, therefore, a good number? Or is 62 considered many deaths? Sorry for the simplistic questions, I just want to understand if my Xoma shares are going to take off or tank. Thanks in advance! Catherine